Context: Variations in body composition parameters can significantly impact the risk of developing type 2 diabetes (T2D). Proactive management of these parameters can play a crucial role in prevention. The objective of our study was to examine the variation in body composition parameters among patients at risk of type 2 diabetes. Methods: We conducted a cross-sectional study involving 333 patients. Diabetes risk was assessed using the FINDRISC score, and body composition was evaluated using bioelectrical impedance analysis (BIA). One-way analysis of variance (ANOVA) and Duncan’s post hoc test (95% CI, alpha = 0.05) were performed for comparisons using R software. Results: The mean age of the patients was 47 ± 13 years, with a female predominance (63%). Of the participants, 48.4% had a low risk, 28.5% had a high risk, and 6% were at risk of developing T2D within 10 years. BMI was highest among patients at risk of T2D within 10 years (34.3 ± 3.6 kg/m2). Muscle mass was highest in non-diabetic individuals (36 ± 6 kg) and lowest in the increased-risk group (22 ± 2 kg), while bone mass was highest in the same group (3.15 ± 0.51 kg). The percentage of body water was highest among non-diabetics (49.0% ± 6.7%), whereas the percentage of body fat reached its maximum in the increased-risk group (52% ± 4%). Visceral fat was also higher in patients at increased risk (13.7 ± 3.9 kg) and those at risk within 10 years (13.1 ± 1.1 kg). Conclusion: Body composition varies significantly according to the risk of developing type 2 diabetes.
References
[1]
Zhang, Y., Pan, X., Chen, J., Xia, L., Cao, A., Zhang, Y., et al. (2019) Combined Lifestyle Factors and Risk of Incident Type 2 Diabetes and Prognosis among Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Diabetologia, 63, 21-33. https://doi.org/10.1007/s00125-019-04985-9
[2]
Yuan, S., Gill, D., Giovannucci, E.L. and Larsson, S.C. (2022) Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation. ClinicalGastroenterologyandHepatology, 20, e529-e537. https://doi.org/10.1016/j.cgh.2020.12.034
[3]
Shojima, N. and Yamauchi, T. (2023) Progress in Genetics of Type 2 Diabetes and Diabetic Complications. JournalofDiabetesInvestigation, 14, 503-515. https://doi.org/10.1111/jdi.13970
[4]
Zheng, Y., Ley, S.H. and Hu, F.B. (2017) Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. NatureReviewsEndocrinology, 14, 88-98. https://doi.org/10.1038/nrendo.2017.151
[5]
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. DiabetesResearchandClinicalPractice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
[6]
Goedecke, J.H. and Mendham, A.E. (2022) Pathophysiology of Type 2 Diabetes in Sub-Saharan Africans. Diabetologia, 65, 1967-1980. https://doi.org/10.1007/s00125-022-05795-2
[7]
Bigna, J.J., Nansseu, J.R., Katte, J. and Noubiap, J.J. (2018) Prevalence of Prediabetes and Diabetes Mellitus among Adults Residing in Cameroon: A Systematic Review and Meta-analysis. DiabetesResearchandClinicalPractice, 137, 109-118. https://doi.org/10.1016/j.diabres.2017.12.005
[8]
Schuster, D. (2010) Obesity and the Development of Type 2 Diabetes: The Effects of Fatty Tissue Inflammation. Diabetes, MetabolicSyndromeandObesity: TargetsandTherapy, 3, 253-262. https://doi.org/10.2147/dmso.s7354
[9]
Fontana, L., Eagon, J.C., Trujillo, M.E., Scherer, P.E. and Klein, S. (2007) Visceral Fat Adipokine Secretion Is Associated with Systemic Inflammation in Obese Humans. Diabetes, 56, 1010-1013. https://doi.org/10.2337/db06-1656
[10]
Bianchi, L. and Volpato, S. (2016) Muscle Dysfunction in Type 2 Diabetes: A Major Threat to Patient’s Mobility and Independence. ActaDiabetologica, 53, 879-889. https://doi.org/10.1007/s00592-016-0880-y
[11]
Maliszewska, K., Adamska-Patruno, E. and Kretowski, A. (2019) The Interplay between Muscle Mass Decline, Obesity, and Type 2 Diabetes. PolishArchivesofInternalMedicine, 129, 809-816. https://doi.org/10.20452/pamw.15025
[12]
Andreasen, A.S., Kelly, M., Berg, R.M.G., Møller, K. and Pedersen, B.K. (2011) Type 2 Diabetes Is Associated with Altered NF-κB DNA Binding Activity, JNK Phosphorylation, and AMPK Phosphorylation in Skeletal Muscle after LPS. PLOS ONE, 6, e23999. https://doi.org/10.1371/journal.pone.0023999
[13]
Pourhoseingholi, M.A., Vahedi, M. and Rahimzadeh, M. (2013) Sample Size Calculation in Medical Studies. GastroenterolHepatolBedBench, 6, 14-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017493/
[14]
Atayoglu, A.T., Inanc, N., Başmisirli, E. and Çapar, A.G. (2020) Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for Diabetes Screening in Kayseri, Turkey. PrimaryCareDiabetes, 14, 488-493. https://doi.org/10.1016/j.pcd.2020.01.002
[15]
Ward, L.C. (2018) Bioelectrical Impedance Analysis for Body Composition Assessment: Reflections on Accuracy, Clinical Utility, and Standardisation. European Journal of ClinicalNutrition, 73, 194-199. https://doi.org/10.1038/s41430-018-0335-3
Barbosa-Silva, M.C.G. and Barros, A.J. (2005) Bioelectrical Impedance Analysis in Clinical Practice: A New Perspective on Its Use Beyond Body Composition Equations. CurrentOpinioninClinicalNutrition&MetabolicCare, 8, 311-317. https://doi.org/10.1097/01.mco.0000165011.69943.39
[18]
Boutari, C., DeMarsilis, A. and Mantzoros, C.S. (2023) Obesity and Diabetes. DiabetesResearchandClinicalPractice, 202, Article ID: 110773. https://doi.org/10.1016/j.diabres.2023.110773
[19]
Chandrasekaran, P. and Weiskirchen, R. (2024) The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. InternationalJournalofMolecularSciences, 25, Article 1882. https://doi.org/10.3390/ijms25031882
[20]
Zatterale, F., Longo, M., Naderi, J., Raciti, G.A., Desiderio, A., Miele, C., et al. (2020) Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. FrontiersinPhysiology, 10, Article 1607. https://doi.org/10.3389/fphys.2019.01607
[21]
Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., et al. (2006) Recent Advances in the Relationship between Obesity, Inflammation, and Insulin Resistance. European Cytokine Network, 17, 4-12.
[22]
Merz, K.E. and Thurmond, D.C. (2020) Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. ComprehensivePhysiolog, 10, 785-809. https://doi.org/10.1002/cphy.c190029
[23]
Koistinen, H.A. and Zierath, J.R. (2002) Regulation of Glucose Transport in Human Skeletal Muscle. AnnalsofMedicine, 34, 410-418. https://doi.org/10.1080/078538902321012351
[24]
Sinacore, D.R. and Gulve, E.A. (1993) The Role of Skeletal Muscle in Glucose Transport, Glucose Homeostasis, and Insulin Resistance: Implications for Physical Therapy. PhysicalTherapy, 73, 878-891. https://doi.org/10.1093/ptj/73.12.878
[25]
Ferron, M. and Lacombe, J. (2014) Regulation of Energy Metabolism by the Skeleton: Osteocalcin and Beyond. ArchivesofBiochemistryandBiophysics, 561, 137-146. https://doi.org/10.1016/j.abb.2014.05.022
[26]
Armstrong, L.E., Barquera, S., Duhamel, J.‐F., Hardinsyah, R., Haslam, D. and Lafontan, M. (2012) Recommendations for Healthier Hydration: Addressing the Public Health Issues of Obesity and Type 2 Diabetes. ClinicalObesity, 2, 115-124. https://doi.org/10.1111/cob.12006
[27]
Kahn, S.E., Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms Linking Obesity to Insulin Resistance and Type 2 Diabetes. Nature, 444, 840-846. https://doi.org/10.1038/nature05482
[28]
Després, J. (2012) Body Fat Distribution and Risk of Cardiovascular Disease. Circulation, 126, 1301-1313. https://doi.org/10.1161/circulationaha.111.067264
[29]
Buyinza, R., Nsamba, J., Muyingo, A., Matovu, N., Nabirye, G., Kantengwa, A., et al. (2023) Body Composition of Type 2 Diabetes Patients in Uganda: A Case-Control Study. JournalofPublicHealthinAfrica, 14, a292. https://doi.org/10.4081/jphia.2023.2249
[30]
Kistan, J., Wing, J., Tshabalala, K., Van Hougenhouck-Tulleken, W. and Basu, D. (2024) Body Composition Estimates from Bioelectrical Impedance and Its Association with Cardiovascular Risk. AfricanJournalofPrimaryHealthCare&FamilyMedicine, 16, a4587. https://doi.org/10.4102/phcfm.v16i1.4587
[31]
American Diabetes Association Professional Practice Committee (2024) 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025. DiabetesCare, 48, S50-S58. https://doi.org/10.2337/dc25-S003
[32]
Bull, F.C., Al-Ansari, S.S., Biddle, S., Borodulin, K., Buman, M.P., Cardon, G., et al. (2020) World Health Organization 2020 Guidelines on Physical Activity and Sedentary Behaviour. BritishJournalofSportsMedicine, 54, 1451-1462. https://doi.org/10.1136/bjsports-2020-102955
